Improve sleep using vestibular stimulation
- Trial ID
- NCT06386497
- Official Title
- Overnight Treatment of Parkinson's Disease Using Vestibular Stimulation From a Rocking Bed (Somnomat Casa) - A Feasibility Study
- Goal
- Improve sleep using vestibular stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Study Type
- INTERVENTIONAL
- Enrollment
- 15 participants
- Conditions
- Parkinson Disease
- Interventions
- Nocturnal translational vestibular stimulation
Plain-Language Summary
It tests whether gentle overnight rocking from a Somnomat Casa bed can improve sleep quality and reduce nighttime fragmentation for people with Parkinson's. The bed delivers slow translational vestibular stimulation to the inner ear, a non-drug way to nudge the brain toward deeper, more consolidated sleep, and the intervention is used while participants stay on their usual Parkinson's, antidepressant, and sleep medications. This is a small feasibility study with about 15 participants, using a noninvasive device and excluding people with bilateral deep brain stimulation. Adults 18 to 85 with Parkinson's by MDS criteria who have poor sleep (PSQI > 5), speak German, are not demented (MoCA ≥ 24), weigh under 150 kg, and have no major psychiatric or other neurological diseases can apply.
Locations
- Insel Gruppe AG, University Hospital Bern, Bern, Switzerland
- ETH Zurich, Sensory-Motor Systems Lab, IRIS, Zurich, Switzerland
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Nocturnal translational vestibular stimulation. It tests whether gentle overnight rocking from a Somnomat Casa bed can improve sleep quality and reduce nighttime fragmentation for people with Parkinson's. The bed delivers slow translational vestibular stimulation to the inner ear, a non-drug way to nudge the brain toward deeper, more consolidated sleep, and the intervention is used while participants stay on their usual Parkinson's, antidepressant, and sleep medications. This is a small feasibility study with about 15 participants, using a noninvasive device and excluding people with bilateral deep brain stimulation. Adults 18 to 85 with Parkinson's by MDS criteria who have poor sleep (PSQI > 5), speak German, are not demented (MoCA ≥ 24), weigh under 150 kg, and have no major psychiatric or other neurological diseases can apply.
- Who can participate?
- Participants must be between 18 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.